Lv31
320 积分 2022-06-29 加入
Overcoming Barriers: Clinical Translation of siRNA Nanomedicines
5天前
已完结
siRNA-Based Novel Therapeutic Strategies to Improve Effectiveness of Antivirals: An Insight
5天前
已完结
Antisense Drug Technology
10天前
已关闭
Control of Hepatitis B Virus with Imdusiran, a Small Interfering RNA Therapeutic
14天前
已完结
Does siRNA-based therapy require pegylated interferon-alfa-2a to cure HBV infection?
14天前
已完结
Why is the functional cure rate of young children with chronic hepatitis B receiving antiviral therapy considerably high?
14天前
已完结
Updated Guidelines for the Prevention and Management of Chronic Hepatitis B—World Health Organization 2024 Compared With China 2022 HBV Guidelines
16天前
已关闭
Long-term and efficient inhibition of hepatitis B virus replication by AAV8-delivered artificial microRNAs
17天前
已完结
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study
18天前
已完结
Control of Hepatitis B Virus with Imdusiran, a Small Interfering RNA Therapeutic
2个月前
已完结
皖公网安备34019202002308
